Attributes | Values |
---|
rdf:type
| |
rdfs:seeAlso
| |
Description
| - The project will document and monitor the natural course and study the pathophysiology of Primary Antibody Deficiencies (PAD). PADs are rare inborn errors of the immune system with an estimated incidence of <1:25.000. The defective immunity in patients with PAD causes an increased susceptibility to recurrent infections of the respiratory- and gastro-intestinal tract as well as ill defined co-morbidity including granulomatous disease, lymphocytic organ infiltration and (paradoxically) autoimmunity. Our consortium cares for more than 1000 PAD patients, representing approx. 50% of the patients registered in Europe, many of them being children. We propose to: 1. Combine clinical and research data in a central online registry, complemented by a sample repository (WP1) 2. Elucidate the genetic cause of PADs by linkage analysis and candidate gene approaches (WP2) 3. Establish in vitro models for B cell differentiation steps that are defective in PADs such as in vitro class switch recombination, and si (en)
- The project will document and monitor the natural course and study the pathophysiology of Primary Antibody Deficiencies (PAD). PADs are rare inborn errors of the immune system with an estimated incidence of <1:25.000. The defective immunity in patients with PAD causes an increased susceptibility to recurrent infections of the respiratory- and gastro-intestinal tract as well as ill defined co-morbidity including granulomatous disease, lymphocytic organ infiltration and (paradoxically) autoimmunity. Our consortium cares for more than 1000 PAD patients, representing approx. 50% of the patients registered in Europe, many of them being children. We propose to: 1. Combine clinical and research data in a central online registry, complemented by a sample repository (WP1) 2. Elucidate the genetic cause of PADs by linkage analysis and candidate gene approaches (WP2) 3. Establish in vitro models for B cell differentiation steps that are defective in PADs such as in vitro class switch recombination, and si
|
Title
| - Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes (en)
- Pathophysiology and Natural Course of Primary Antibody Deficiency (PAD) Syndromes
|
skos:notation
| |
http://linked.open...avai/cep/aktivita
| |
http://linked.open...kovaStatniPodpora
| |
http://linked.open...ep/celkoveNaklady
| |
http://linked.open...datumDodatniDoRIV
| |
http://linked.open...i/cep/druhSouteze
| |
http://linked.open...ep/duvernostUdaju
| |
http://linked.open.../cep/fazeProjektu
| |
http://linked.open...ai/cep/hlavniObor
| |
http://linked.open...hodnoceniProjektu
| |
http://linked.open...vai/cep/kategorie
| |
http://linked.open.../cep/klicovaSlova
| - Immunodeficiency; antibody deficiency; genetic; database; clinical; immunoglobulin; mutation; candidate gene; class switch recombination; humanised mice; lentiviral vector (en)
|
http://linked.open...ep/partnetrHlavni
| |
http://linked.open...inujicichPrijemcu
| |
http://linked.open...cep/pocetPrijemcu
| |
http://linked.open...ocetSpoluPrijemcu
| |
http://linked.open.../pocetVysledkuRIV
| |
http://linked.open...enychVysledkuVRIV
| |
http://linked.open...lneniVMinulemRoce
| |
http://linked.open.../prideleniPodpory
| |
http://linked.open...iciPoslednihoRoku
| |
http://linked.open...atUdajeProjZameru
| |
http://linked.open...usZobrazovaneFaze
| |
http://linked.open...ai/cep/typPojektu
| |
http://linked.open...ep/ukonceniReseni
| |
http://linked.open.../cep/vedlejsiObor
| |
http://linked.open...ep/zahajeniReseni
| |
http://linked.open...jektu+dodavatelem
| - Following the condition that the candidate of financial contribution was evaluated and afterwards selected by international provider in accordance with the rules of the program the Ministry of Education, Youth ans Sports does not realize the evaluation of project results. The project is evaluated only after its approval by an international provider. (en)
- Hodnocení výsledků řešení ministerstvo neprovádí, neboť podmínkou podpory je, že uchazeč byl vybrán mezinárodním poskytovatelem v souladu s pravidly příslušného programu. Projekt je hodnocen až po jeho schválení mezinárodním poskytovatelem. (cs)
|
http://linked.open...tniCyklusProjektu
| |
http://linked.open...n/vavai/cep/vyzva
| |
http://linked.open.../cep/klicoveSlovo
| - Immunodeficiency
- database
- genetic
- mutation
- antibody deficiency
- candidate gene
- class switch recombination
- clinical
- humanised mice
- immunoglobulin
|
is http://linked.open...vavai/cep/projekt
of | |